reprotech responds

ReproTech would like to speak out in support of Testicular Cancer Awareness Month. Testicular Cancer is the most common cancer in males between the ages of 15 and 34. The fact that this cancer hits such young men means that many of those men diagnosed with testicular cancer have yet to finish their families and many haven’t even started their families. In addition to the awareness campaign for monthly self-examination, we also want to point out the need for fertility preservation discussions with the medical care team for every newly diagnosed testicular cancer patient. Below is a short podcast from Dr. Landon Trost of the Mayo Clinic which many might find helpful.

link-symbol Testicular Cancer and Fertility Preservation with Dr. Landon Trost Podcast

-Brent Hazelrigg, CEO



We're ReproTech - The World Wide Leader in Safe Storage

ReproTech's goal is to make reproductive tissue banking services available to cancer patients, and all infertility patients wishing to preserve their fertility by making cryostorage more attainable, affordable and reliable, through ease of access, financial assistance, safety in shipping and security of storage.

ReproTech will provide fertility preservation services to Oncology patients facing fertility compromising treatment and long term cryostorage to Fertility patients through our network of expert providers and at each of our regional cryostorage centers.

ReproTech's attentive service, validated policies and protocols, regulatory compliance and professionally designed facilities will provide both healthcare professionals and patients with the peace of mind they desire and deserve.

Top